Tafamidis Active Not Recruiting Phase 4 Trials for Transthyretin (TTR) Amyloid Cardiomyopathy Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT04814186A Study to Assess the Safety and Efficacy Of Tafamidis In Chinese Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)